Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery

被引:0
|
作者
Li, Li [1 ]
Huang, Jia-Ling [1 ]
Liu, Qi-Cai [2 ]
Wu, Pei-Hong [1 ]
Liu, Ran-Yi [1 ]
Zeng, Yi-Xin [1 ]
Huang, Wen-Lin [1 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China
[2] Guangzhou Med Coll, Expt Med Res Ctr, Guangzhou 510182, Guangdong, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the expression of adenovirus-mediated human endostatin (Ad/hEndo) gene transfer and its effect on the growth of hepatocellular carcinoma (HCC) BEL-7402 xenografted tumors. METHODS: Immunohistochemistry analysis with an anti-endostatin antibody was preformed to detect endostatin protein expression in HCC BEL-7402 cells infected with Ad/hEndo. MTT assay was used to investigate the effects of Ad/hEndo on proliferation of human umbilical vein endothelial cells (HUVEC). Intra-tumoral injections of 1x10(9) pfu Ad/hEndo was given to treat BEL-7402 xenografted tumors in nude mice once weekly for 6 wk. Mice received injections of Ad/LacZ and DMEM were regarded as control groups. After intra-turmoral administration with Ad/hEndo, the endostatin mRNA expression in tumor tissue was analyzed by Northern blotting, and plasma endostatin levels were determined using enzyme-linked immunosorbent assay (ELISA). RESULTS: High level expression of endostatin gene was detected in the infected HCC BEL-7402 cells. Ad/hEndo significantly inhibited HUVEC cell proliferation by 57.2% at a multiplicity of infection (MOI) of 20. After 6-week treatment with Ad/hEndo, the growth of treated tumors was inhibited by 46.50% compared to the Ad/LacZ control group (t=2.729, P<0.05) and by 48.56% compared to the DMEM control group (t=2.485, P<0.05). The ratio of mean tumor volume in treated animals to mean tumor volume in the control animals (T:C ratio) was less than 50% after 24 d of treatment. Endostatin mRNA in tumor tissue was clearly demonstrated as a band of approximately 1.2 kb, which was the expected size of intact and functional endostatin. Plasma endostatin levels peaked at 87.52 +/- 8.34 ng/mL at d 3 after Ad/hEndo injection, which was significantly higher than the basal level (12.23 +/- 2.54 ng/mL). By d 7, plasma levels dropped to nearly half the peak level (40.34 +/- 4.80 ng/mL). CONCLUSION: Adenovirus-mediated human endostatin gene can successfully express endogenous endostatin in vitro and in vivo, and significantly inhibit the growth of BEL-7402 xenografted liver tumors in nude mice.
引用
收藏
页码:1867 / 1871
页数:5
相关论文
共 50 条
  • [31] Prostate cancer gene therapy using recombinant adenovirus expressing a novel tumor suppressor gene pHyde
    Steiner, MS
    Zhang, XW
    Wang, Y
    Lu, Y
    CANCER GENE THERAPY, 2000, 7 (12) : S2 - S2
  • [32] Cancer gene therapy with a recombinant adenovirus expressing a Von Hippel-Lindau tumor suppressor gene
    Kim, M
    Katayose, Y
    Li, Q
    Rakkar, AN
    Li, Z
    Hwang, SG
    Katayose, D
    Trepel, J
    Cowan, KH
    Seth, P
    CANCER GENE THERAPY, 1999, 6 (06) : S1 - S2
  • [33] Utilizing adenovirus vectors for gene delivery in cancer
    Kasala, Dayananda
    Choi, Joung-Woo
    Kim, Sung Wan
    Yun, Chae-Ok
    EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (03) : 379 - 392
  • [34] Mutant adenovirus as a gene therapy of cancer
    Sunamura, M
    HUMAN GENE THERAPY, 1999, 10 (05) : 842 - 842
  • [35] Adenovirus gene therapy for ovarian cancer
    Russell, W
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (10): : 706 - 707
  • [36] Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
    Wold, William S. M.
    Toth, Karoly
    CURRENT GENE THERAPY, 2013, 13 (06) : 421 - 433
  • [37] Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy
    Høgset A.
    Engesæter B.O.
    Prasmickaite L.
    Berg K.
    Fodstad Ø.
    Mælandsmo G.M.
    Cancer Gene Therapy, 2002, 9 (4) : 365 - 371
  • [38] Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy
    Hogset, A
    Engesæter, BO
    Prasmickaite, L
    Berg, K
    Fodstad, O
    Mælandsmo, GM
    CANCER GENE THERAPY, 2002, 9 (04) : 365 - 371
  • [39] Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
    Li, Wei
    Zhao, Xiaoxu
    Du, Bin
    Li, Xin
    Liu, Shuhao
    Yang, Xiao-Yan
    Ding, Hui
    Yang, Wende
    Pan, Fan
    Wu, Xiaobo
    Qin, Li
    Pan, Yunlong
    SCIENTIFIC REPORTS, 2016, 6
  • [40] Recombinant adenovirus vectors for tumor-specific gene delivery and expression
    Lieber, A
    Steinwaerder, D
    Mi, J
    Shayakhmetov, D
    CANCER GENE THERAPY, 2001, 8 (09) : 687 - 688